In SLE patients prone to flaring, increased PTPN22 expression in activated CD8+ T cells is a biomarker of poor prognosis (17), which again indicates an activated phenotype in flaring autoimmunity. This evidence concerns the gene CD8A and systemic lupus erythematosus.